Roger Albright

Roger Albright is an experienced professional in the field of clinical research and regulatory programs, currently serving as Associate Director of Regulatory Programs at Ora, Inc. since July 2018, where oversight of Medical Device Clinical Program regulatory support is a key responsibility. Concurrently, Roger serves as Clinical Development Project Manager at Massachusetts General Hospital, focusing on advancing therapeutics from concept to market approval within the Translational Medicine Group. Prior experience includes Director of Clinical Services at Foresight Regulatory Strategies, where responsibilities encompassed proposal development and client services. Roger's background also includes roles as Sr. Program Manager at Molecular Geodesics Inc. and Project Manager at PAREXEL, managing clinical projects in various therapeutic areas. An early career involved managerial roles in clinical affairs at Polymer Technology Corp. and clinical research at Bausch & Lomb. Roger holds an MBA in International Business from Questrom School of Business, Boston University, and a BA in Marketing from Rochester Institute of Technology.